07:00 , Sep 28, 2015 |  BC Week In Review  |  Clinical News

Taxis Pharmaceuticals preclinical data

Taxis said oral TXA709 plus cefdinir showed synergistic activity against all MRSA strains tested in a mouse model of peritonitis systemic infection. Additionally, the combination significantly reduced detectable frequency of resistance (FOR), a measure of...
08:00 , Oct 30, 2006 |  BioCentury  |  Regulation

On the market

On the market...
07:00 , Jul 9, 2004 |  BC Extra  |  Top Story

Abbott meets Street

ABT reported second quarter EPS of $0.54, meeting the Street's estimate and up 15% from EPS of $0.47 in the same period last year. Second quarter global sales were $4.7 billion, up 14% compared with...